Date Speaker(s) Presentation Title
December 2017

Jada G. Hamilton, Ph.D., M.P.H.
Assistant Attending Psychologist and Assistant Member Department of Psychiatry and Behavioral Sciences Memorial Sloan Kettering Cancer Center and Memorial Hospital

Precision Oncology and Genetic Risk Information: Exploring Patients' Preferences and Responses
October 2017

Jessica Faupel-Badger, Ph.D.
Director, Postdoctoral Research Associate (PRAT) Program. National Institute of General Medical Sciences. National Institutes of Health

Careers in cancer prevention research - Reflections from a large outcomes evaluation study
October 2017

Tamaro Hudson, Ph.D., MPH
Assistant Professor, Department of Pharmacology at Howard University. Health Research Specialist at Washington VA Medical Center

Utilizing Biomarker Signature Pairs To Develop Gene Therapeutic Viral Delivery Platforms For Treating Prostate Cancer
September 2017

Carol Estwing Ferrans, PhD, RN, FAAN
Associate Dean for Research Harriet H. Werley Endowed Chair in Nursing Research Professor, Biobehavioral Health Sciences, College of Nursing University of Illinois at Chicago Chicago, IL

Translating Research into Policy: Reducing Breast Cancer Disparities in Illinois
June 2017

Reginald Tucker-Seeley, ScD, ScM, MA
Professor, Leonard Davis School of Gerontology at the University of Southern California

Measuring financial well-being in cancer prevention research: Results from the Money-Health Connection Study
June 2017

Matthew W. Kreuter, PhD, MPH
Associate Dean & Kahn Family Professor of Public Health at Washington University in St. Louis

Lessons Learned from 25 Years of Health Communication Research to Eliminate Health Disparities
May 2017

Ann Hsing, PhD, MPH
Stanford University

A Fantastic Epidemiology Journey: from China to Africa and back
May 2017

Ellen V. Sigal, PhD
Friends of Cancer Research

Why Advocacy and Policy Matter: Promoting Research and Innovation
April 2017

Judith Prochaska, PhD, MPH
Stanford Medicine - Stanford University

Digital Tools for Cancer Prevention: Extending Reach and Engagement
April 2017

Steven D. Pearson, MD, MSc, FRCP
Founder and President, Institute for Clinical Economic Review (ICER), Boston, MA

If Medicare Were to Negotiate Drug Prices, How Would it Determine a ‘Fair’ Price for a Cancer Treatment?
March 2017

Angela Fagerlin, PhD
Professor & Chair, Department of Population Health Sciences, University of Utah

The Impact of Shared Decision-making Interventions on Prostate Cancer Treatment Decision-making
March 2017

Julie R. Palmer, ScD
Boston University

Type 2 Diabetes in Relation to Breast Cancer Risk: Results from the Black Women’s Health Study
March 2017

Kate Sweeny, PhD
University of California, Riverside Riverside, CA

The Psychological Impact of Awaiting Breast Diagnosis: A Preliminary Picture
February 2017

Betty Ferrell, PhD, MA, FAAN, FPCN
Beckman Research Institute of City of Hope

The Integration of Palliative Care into Standard Oncology Care
January 2017

Jim Evans, MD, PhD
The University of North Carolina at Chapel Hill

Cancer Prevention, Genomics, and the PMI
January 2017

Andrew Briggs, DPhil, MSc
University of Glasgow

Designing a value framework for oncology: what are the issues with existing frameworks and can we do better?
January 2017

Shiriki K. Kumanyika, PhD, MPH
University of Pennsylvania

Obesity, Cancer Prevention, and Health Equity. The Promise of Public Health Approaches
January 2017

Victoria L. Champion, PhD, RN, FAAN
Indiana University Simon Cancer Center

How do I develop a program of Cancer Control Science that will make a difference?
December 2016

Sudhir Srivastava, PhD, MPH, MS
NCI Division of Cancer Prevention

My Journey to Cancer Biomarker Research: Building a Translational Science Infrastructure - It Takes a Village
November 2016

Valerie M. Weaver, PhD
University of California San Francisco

Force and Breast Cancer Risk
October 2016

Susan E. Olivo-Marston, PhD, MPH
The Ohio State University

Obesity and Colon Cancer…Does Timing Matter?”
October 2016

Erin Kent, PhD, MS
National Cancer Institute

Moving from Patient- to Family-Centric: Progress and Remaining Challenges in Cancer Caregiving
October 2016

Alan G. Nyitray, PhD
National Cancer Institute

The Epidemiology of Anal HPV in High Risk Men and Novel Opportunities for Anal Cancer Screening
September 2016

Elizabeth A. Platz, ScD, MPH
John Hopkins Bloomberg School of Public Health

Enhancing the Infrastructure of a Cardiovascular Disease Cohort for Cancer Edpidemiology Research: Efforts, Findings, and Opportunities
June 2016

Douglas L. Weed, MD, PhD, MPH
DLW Consulting Services, LLC

After the NCI: Methods, Mountains, and Mischief
May 2016

Sarah Gehlert, PhD
Washington University in St. Louis

The Effect of Social Influences on African-American Breast Cancer Patients
May 2016

Melinda L. Irwin, PhD, MPH
Yale School of Medicine

Energy Balance Interventions: The New Adjuvant Therapy
May 2016

Nancy Krieger, PhD
Boston University

Segregation, Jim Crow, Racism, Embodied History & the People’s Health: Implications for Cancer Registries, Research & Prevention
April 2016

Ulrike Boehmer, PhD
Boston University

Cancer and the LGBT Community: Reporting on an Understudied Population
April 2016

Sandro Galea, MD, MPH, DrPH
Boston University

The Principles of Population Health Science: Implications for Cancer Prevention